|
HS Code |
424747 |
| Chemical Name | Beta-Guanidinopropionic Acid |
| Synonyms | β-Guanidinopropionic Acid, GPA |
| Molecular Formula | C4H9N3O2 |
| Molecular Weight | 131.13 g/mol |
| Cas Number | 463-00-3 |
| Appearance | White crystalline powder |
| Solubility In Water | Soluble |
| Melting Point | Higher than 200°C (decomposes) |
| Storage Conditions | Store at room temperature, in a dry place |
| Ph Value In Solution | Approximately 6-7 (1% solution) |
As an accredited Beta-Guanidinopropionic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Beta-Guanidinopropionic Acid, 100 grams: Supplied in a sealed, white HDPE bottle with tamper-evident cap and clearly labeled chemical information. |
| Shipping | Beta-Guanidinopropionic Acid is shipped in tightly sealed, chemical-resistant containers to protect against moisture and contamination. Packages are clearly labeled and comply with applicable transportation regulations. Standard shipping is via ground or air, depending on destination and urgency. Temperature control may be provided to maintain product stability during transit. |
| Storage | Beta-Guanidinopropionic Acid should be stored in a tightly sealed container at room temperature, away from direct sunlight, moisture, and incompatible substances such as strong oxidizers. It should be kept in a well-ventilated, dry area, preferably in a chemical storage cabinet. Ensure proper labeling and access is limited to trained personnel to maintain safety and chemical stability. |
Applications of Beta-Guanidinopropionic Acid in Industrial ManufacturingBeta-Guanidinopropionic Acid has established technical relevance in several specialized production routes across fine chemicals, bioprocessing inputs, diagnostics, and advanced materials sectors. As a core manufacturer, we supply consistent, quality-verified material for integration into complex downstream workflows, meeting exacting industrial and regulatory requirements in each sector. 1. Cell Culture Nutrient Premixes for BioprocessingBioprocessing facilities source Beta-Guanidinopropionic Acid to modulate cellular energy metabolism when developing or scaling up mammalian and microbial cell cultures. Users incorporate it selectively into custom growth media to control creatine kinase activity, optimize ATP usage, and influence cell line stability during recombinant protein, monoclonal antibody, or vaccine production. Scientists typically validate inclusion through extensive internal qualification, focusing on cell proliferation and yield endpoints before commercial scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Biochemical Research Reagents for Cellular Energy Metabolism StudiesResearchers utilize this compound as a guanidino analog to study creatine transport, ATP homeostasis, and mitochondrial function in various cell types. This allows precise pharmacological intervention in metabolic assays or preclinical screening platforms. Laboratories source GMP-compliant or research-grade batches to minimize batch-to-batch variability and contaminants that could interfere with energy metabolism readouts. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Standard for Creatine Transport and Metabolism DiagnosticsClinical and pharmaceutical labs include Beta-Guanidinopropionic Acid as a reference standard during metabolic profiling assays. These workflows involve quantifying creatine and guanidino compounds in biological samples for inborn errors of metabolism, nutritional studies, or supplement quality control. Laboratories require high-purity, precisely characterized material to assure traceable calibration curves in LC/MS, HPLC, or enzymatic assay platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Bioactive Compound Synthesis in Pharmaceutical ManufacturingPharmaceutical synthesis teams employ Beta-Guanidinopropionic Acid as a protected guanidine group source or metabolic modulator in multi-step synthesis of structurally related APIs or reference substances. The compound’s chemically reactive groups allow incorporation or transformation under controlled reaction conditions, supporting route scouting and scalable production of functionalized guanidines. Full traceability from raw material intake through final QA release remains critical for regulatory dossiers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Beta-Guanidinopropionic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Daily life in a chemical plant sheds light on the real behavior of Beta-Guanidinopropionic Acid in the world, far beyond textbook explanations. Unlike resellers and bulk consolidators, a manufacturer tracks this product from reaction vessel to finished drum, refining process details that impact every shipment. This close connection to the plant floor grants insight into beta-GPA's true nature: a guanidino acid with research-driven applications—particularly in biochemistry, muscle metabolism, and cellular energy transfer studies.
Beta-Guanidinopropionic Acid, or beta-GPA, doesn’t attract the spotlight like common amino acids, yet researchers have steadily increased demand for high-purity, structurally verified material. We focus on the monohydrate form, as it demonstrates better handling stability and reproducibility in most research settings. The solid product carries a fine, free-flowing texture—never caked, never unreliable—because our post-reaction washing and drying stages have been adjusted over time to prevent residual salt contamination.
Interest in beta-GPA grew after studies showed it behaves as a creatine analog. That small molecular shift—exchanging a methyl group for a hydrogen—gives beta-GPA a unique effect on cellular uptake systems. Unlike creatine, it not only competes for transport across muscle cell membranes but also elicits different downstream metabolic changes, especially over sustained exposure. This makes it valuable in physiological research focused on AMP-activated protein kinase or on adaptations to cellular energy stress.
Some mistakenly lump beta-GPA with other guanidine derivatives or assume lab chemical sources share the same purity level as ingredients intended for biological studies. But in direct synthesis, a manufacturer understands the distinct challenges: the guanidination step generates byproducts like urea or side-chain cyclization products that resist traditional filtration methods. Dialing in recrystallization temperature and solvent ratios helps keep these impurities well below accepted thresholds. We verify structure and purity by proton NMR and HPLC after every batch—not just spot checks—because lab reproducibility depends on molecular precision.
The largest demand for beta-GPA still comes from academic and contract research organizations. Some are studying its effect as a non-transported creatine analog in muscle cells. Others explore its capability to drive adaptations in mitochondria, much like caloric restriction mimetics. These applications require more than standard reagent quality—minute impurities or shifts in hydration state can throw off dose response curves. Having direct sightline to every preparative step allows us to catch these anomalies before they reach the end user.
Newer applications have quietly emerged, especially in metabolic syndrome or diabetes models, where researchers explore beta-GPA’s role in influencing AMPK or related cellular energy pathways. This research hinges on repeatable results, and the batch consistency we achieve through rigorous batchwise inventory tracebacks and redundant analytical checks keeps experimental data reliable. From speaking with lab partners and regularly reviewing usage feedback, we know that uncontrolled variance in fine chemicals leads to wasted time, budget overruns, and missed publication deadlines.
Years ago, we noticed complaints about beta-GPA’s tendency to absorb moisture, resulting in lumping and dosing errors. Early process tweaks centered on reducing post-synthesis drying time, but these changes revealed other issues—not every impurity evaporates at the same rate, and overly aggressive drying sometimes produced material with altered hydration states that complicated analytical assessment. Through a series of post-drying sieving and air-classification steps, the product now resists clumping even after extended warehouse storage.
To avoid confusion with similar sounding compounds, we apply batch-specific labeling that details hydration level, crystallization cycle, and blend lot. This isn’t mandated by regulatory bodies but stems from firsthand interactions with researchers frustrated by poorly traced chemicals in large commercial bins. By standardizing on clear, defensible specifications for both research and pilot production lots, we make sure groups working on different model systems get the consistent quality they expect.
Manufacturers with less experience sometimes source precursor chemicals from secondary suppliers or scale up too quickly, sacrificing batch uniformity. We work with primary synthetic feedstocks and keep synthesis steps in-house to avoid batch-to-batch drift. Beta-GPA’s analogs, like creatine monohydrate or other substituted guanidine acids, each present unique synthesis and purification challenges. Direct manufacturing lays bare these differences. For example, creatine derivatives often develop trace polymerization or salt adducts that resist removal by single-phase crystallization—but with beta-GPA, we control for these side reactions by washing with neutralizing agents timed to lot-specific profiles.
Another subtle but vital difference: beta-GPA reacts differently under high shear mixing than typical amino or guanidine acids. Research users running custom formulations appreciate that our batches dissolve quickly in buffered aqueous media, based on years of refining bulk density and particle size. Industrial users often share feedback on how inconsistent texture from third-party sources causes unpredictable mixing or settling, leading to poor dispersion and data scatter in high-throughput screens.
Chemical safety remains foundational. Our crews monitor pH and temperature parameters during open handling, because beta-GPA powder, while of lower toxicity compared to many laboratory reagents, does present inhalation and dusting risks if not handled with care. Continuous training, localized exhaust, and real-time humidity control minimize incidents—practices refined through decades managing ammonia and guanidine chemistry lines.
In warehousing, a lot of anecdotal knowledge comes into play—beta-GPA stores best in sealed, inert-lined drums kept in environments below 40% relative humidity. Open-top storage or exposure to warehouse steam lines leads to gradual hydration changes, which, though minor at first, can eventually reduce the accuracy of gravimetric dosing or affect downstream blending. Proper sealing, silica gel integration, and real-time moisture tracking systems stem from experiential troubleshooting, not generic guidance. These aren’t codified in global standards, but consistent feedback from our logistics team keeps storage best practices grounded in results.
Third-party distributors sometimes market “ultra-pure” beta-GPA without providing clear production lineage. Direct manufacturers own their quality claims. Each batch runs through validated HPLC for purity and residual solvent analysis, alongside NMR for structure confirmation. Pressure from researchers isn’t about marketing—it comes from hard lessons when published experiments fail due to subtle lot differences in reagent behavior.
We perform not just compositional but functional tests: solubility under simulated lab conditions, pKa titration consistency, and repeat dosing in cell-free and whole-cell assays, in direct reference to historical batch outcomes. This extra step emerged from working with long-term partners who value real-world performance more than technical data sheets. The benefit goes both directions—user feedback triggers production tweaks, whether updating micronization levels or testing effect of storage modifications on hydration retention.
Our dialogue with academic labs and contract research organizations drives process improvements. Researchers often comment on reduced signal drift or background noise after switching to our batch-verified beta-GPA. These conversations don’t happen in a vacuum—they come from resolving inconsistencies experienced with off-the-shelf third-party batches. Institutional users emphasize the time lost retesting protocols or troubleshooting when small impurities skew results, especially in sensitive applications like mitochondrial assays or metabolic stress models.
Technical support does not end at shipment. We provide documented batch histories, answer solvent compatibility questions, and routinely highlight any minor lot-specific deviations, even when they sit within tolerance. Direct manufacturing puts us in the unique position to adjust upcoming synthesis runs around evolving research requirements, avoiding last-minute scrambling or finger pointing common to distributor-led supply chains.
Our plant complies with rigorous local chemical safety, waste minimization, and emissions protocols. Solvent recapture and guanidine cycle closure accomplish more than cost savings—they keep the synthesis process sustainable, limiting environmental impact at source instead of relying on downstream remediation. This carries extra importance as regulatory scrutiny intensifies, especially in export markets sensitive to trace solvents, heavy metals, or waste handling practices.
We see rising requests for documentation related to restricted substance lists, REACH, RoHS, and country-specific green chemistry standards. Direct-from-plant traceability provides a defensible response that third-party operators struggle to match. By controlling synthesis start to finish, we can rapidly supply certificates of analysis, full solvent usage logs, and even minor impurity trend data—essential for labs building experimental pipelines where funding and compliance mean everything.
Synthetic chemistry doesn’t yield its best secrets to textbook readers—deep understanding comes from hands-on adaptation, careful batch archiving, and years of troubleshooting. For beta-GPA, every step from sourcing raw guanidine, controlling exothermic initiation, fine-tuning filtration, to final drying and blending —each impacts the result in measurable ways. Buying from the actual manufacturer builds a direct bridge between the lab bench and the production line, turning experience into improved outcomes and fewer interruptions.
Tools like automated particle sizers or moisture monitors supplement but never replace operator skill developed through pattern recognition and problem solving. Our teams train on real anomaly cases—unanticipated reaction color shifts, precipitation changes with seasonal humidity swings—guiding process batches by real data, not wishful assumptions. This lived experience separates day-to-day chemical manufacturing from the theoretical world of bulk commodity trading.
We stay attuned to shifts in the scientific landscape. More labs now explore how beta-GPA interacts with newly discovered cellular pathways or serve as a tool in energy metabolism studies. Their needs evolve—demand for higher selectivity, new blend formulations, or single-dose packaging tailored to clinical trial workflows. We prototype small custom runs, not to chase every fleeting request, but to maintain versatility and test what’s possible without disrupting baseline quality.
We also receive inquiries about integrating beta-GPA into functional ingredient development or preclinical screening platforms that test beyond basic metabolic stress. Having full manufacturing control lets us analyze and scale up these new blends without diluting oversight or losing the ability to track both process modifications and downstream outcomes. Feedback from these test runs helps further refine standard production, ensuring that lessons learned on the cutting edge keep product reliability high for bread-and-butter academic research contracts.
Beta-GPA demands careful control all the way from synthesis to delivery. A manufacturer’s perspective doesn’t just focus on the chemistry—it tracks logistics, user habits, feedback cycles, and incremental production improvements. Retaining full line-of-sight produces batches with the consistency, physical form, and traceability scientists rely on for credible work. The real differentiator comes from listening to unscripted feedback and adapting quickly, rather than protecting the status quo or chasing commodity margins.
Over many years, we have learned that pushing a fine chemical down the supply chain without manufacturer involvement introduces noise: changing storage habits, mishandling, or mislabeling, each eroding product value. Our long-term customer relationships are built not only on technical data, but on a real understanding of how the product performs in the lab, in storage, during blending, and in experimental workflows. This deep integration of manufacturing knowledge and field-derived adaptation simply can’t be matched by hands-off distributors or traders operating at arm’s length.
From the outside, beta-GPA may look like just another white crystalline powder. But experience teaches that every variable—reaction heat, filtration time, humidity in the air—matters. By making this product from raw materials on site and shepherding each lot through tested, refined processes, we deliver more than a substance. We offer reliability, transparency, and the accumulated insights only a hands-on chemical manufacturer brings.
Scientific progress depends on secure foundations. With beta-GPA, our unique contribution comes not from claims, but from the synergy of deep process knowledge, day-to-day discipline, continuous adaptation, and a network of user-driven feedback. This ensures that every drum delivered supports credible experimentation, reproducible data, and the flexible thinking needed to solve new research challenges as they arise.